![]() |
市场调查报告书
商品编码
1353334
全球静脉器材市场规模、份额、产业趋势分析报告:2023-2030 年按产品类型、最终用户、地区分類的展望与预测Global Intravenous Equipment Market Size, Share & Industry Trends Analysis Report By Product Type (IV catheters, Infusion Pumps, Administration Sets, Needleless Connectors, and Others), By End User, By Regional Outlook and Forecast, 2023 - 2030 |
2030年,静脉注射器材市场规模预计将达219亿美元,预测期内市场年复合成长率率为5.6%。
此外,COVID-19 大流行导致全球医疗保健产业的工作流程中断。 COVID-19 大流行对包括市场在内的医疗保健产业产生了重大影响。由于大流行,静脉注射治疗的需求激增。重症 COVID-19 患者需要静脉输液、药物和支持性护理才能获得有效治疗。这增加了对静脉注射用品(例如给药装置、导管和输液帮浦)的需求。为了降低污染和针刺伤的风险,人们使用了更安全的静脉注射装置,例如安全设计的导管和安全装置。因此,COVID-19对市场扩张产生了显着的正面影响。
然而,维护和故障问题却相当普遍。静脉设备,例如输液帮浦、导管和管道,需要经常维护和校准,以获得最佳性能和准确的药物输送。然而,设备故障可能会扰乱患者照护并给患者带来健康问题。输液帮浦故障、导管或管路阻塞或洩漏可能会导致副作用并降低静脉治疗的有效性。主动维护程序、遵守製造商的说明以及持续的品质改进计划对于减轻维护和设备故障问题至关重要,从而推动市场成长和永续性。
产品类型展望
依产品类型分为输液导管、输液帮浦、给药器、无针连接器等。输液帮浦领域在市场上获得了很大的收益占有率。随着许多特种输液帮浦在世界各地获得认可,输液帮浦领域正在兴起。静脉治疗期间提供的各种特殊输液帮浦类型包括植入式输液帮浦、肠内帮浦、胰岛素帮浦和病人自控镇痛 (PCA) 帮浦。
最终用户的展望
根据最终用户,市场分为医院和诊所、居家医疗等。 2022年,医院和诊所部门占据市场最大的销售份额。此细分市场的成长归因于多种因素,包括广泛使用静脉注射治疗的专业医院部门和病房的可近性和可用性,例如 ICU、急诊室、手术室和普通病房。
区域展望
从区域来看,市场分为北美、欧洲、亚太地区和拉丁美洲/中东/非洲。 2022 年,北美收益占有率最大。北美市场的成长得益于对病人安全的强烈奉献、先进的技术、发达的医疗基础设施、高疾病盛行率、严格的报销法规和领先的市场参与企业等要素。北美医院、门诊手术中心和诊所等先进的医疗设施推动了区域市场的静脉注射器需求。
The Global Intravenous Equipment Market size is expected to reach $21.9 billion by 2030, rising at a market growth of 5.6% CAGR during the forecast period.
Patients who require long-term IV therapies, such as chemotherapy, antibiotics, or parenteral nourishment, may benefit from the comfort and convenience of receiving them at home. Therefore, the Homecare Settings segment registered $2,283.5 million revenue in the market in 2022. Home healthcare gives patients the option to get medical care in a relaxing environment at their homes for treatments like intravenous therapy in an effort to decrease hospital visits and healthcare expenses. Some of the factors impacting the market are innovations in IV solutions technology, increase in the number of surgical operations, and Issues in equipment and its maintenance.
An essential component of contemporary medical practice, IV solutions are used to deliver medications, fluids, and nutrients directly into the bloodstream. The IV solutions demand is being driven by the most recent technological developments in intravenous equipment, which have increased their effectiveness, safety, and efficiency. Intelligent intravenous pumps are one of the most recent technological developments in the IV solution sector. Intelligent IV pumps intelligently change infusion rates based on patient age, weight, and medical condition in order to increase patient safety and lower the possibility of medication errors. Nanotechnology infusion solutions make drug and nutrient delivery to the body more effective and efficient. Additionally, an increase in surgical procedures worldwide is one of the main factors driving the demand for intravenous equipment. Surgical operations encompass a variety of medical interventions that call for medical interventions for various objectives, both in the hospital and outside of it. Infusion pumps, intravenous catheters, and other devices are crucial during surgery for fluid resuscitation, administering anesthetic, and providing postoperative care. Thus, the market will grow due to technological developments in IV solutions and increasing reliance of healthcare providers on these instruments for safe and effective patient care.
Furthermore, The COVID-19 pandemic caused workflow disruptions in the healthcare industry globally. The COVID-19 pandemic had a major effect on the healthcare sector, which included the market. Intravenous treatment saw a spike in demand as a result of the pandemic. Critically ill COVID-19 patients needed intravenous fluids, medicines, and supportive therapies for effective therapy. This raised the need for intravenous supplies such as administration sets, catheters, and infusion pumps. To reduce the danger of contamination and needlestick accidents, intravenous equipment with improved safety features was being used, like safety-engineered catheters and security devices. Therefore, COVID-19 had a largely positive impact on the expansion of the market.
However, substantial maintenance and malfunction issues exist. Intravenous equipment, including infusion pumps, catheters, and tubes, should be frequently maintained and calibrated for optimal performance and accurate medicine delivery. However, device malfunctions could disrupt patient care and pose health concerns to the patients. Failures of the infusion pump, obstructions, or leaks in the catheter and tube lines that may cause adverse effects may reduce the efficacy of intravenous therapy. Proactive maintenance procedures, adherence to manufacturer's instructions, and continual quality improvement programs are crucial to reducing maintenance and equipment failure issues promoting growth and sustainability for the market.
Product Type Outlook
By product type, the market is segmented into IV catheters, infusion pumps, administration sets, needleless connectors, and others. The infusion pumps segment garnered a significant revenue share in the market. There is a rise in the infusion pumps segment due to the increasing acceptance of a number of specialty infusion pumps around the globe. The various specialist infusion pump types that are offered during intravenous therapy include implantable infusion pumps, enteral pumps, insulin pumps, and patient-controlled analgesia (PCA) pumps.
End User Outlook
On the basis of end user, the market is divided into hospitals & clinics, homecare settings, and others. The hospitals and clinics segment held the largest revenue share in the market in 2022. This segment is growing due to a number of circumstances, including the accessibility and availability of specialized hospital departments and units, like ICUs, emergency rooms, surgical suites, and general wards, where IV treatment is widely used.
Regional Outlook
Based on region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the maximum revenue share in the market in 2022. The growth of the North America segment is owing to factors including a strong dedication to patient safety, advanced technology, a well-developed healthcare infrastructure, high illness prevalence, strong reimbursement regulations, and key market participants. The demand for intravenous equipment in the regional market is driven by the sophisticated medical facilities in North America, including hospitals, ambulatory surgical centers, and clinics.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include AngioDynamics, Inc., B. Braun Melsungen AG, ICU Medical, Inc., 3M Company, Teleflex, Inc., Terumo Corporation, Baxter International, Inc., Becton, Dickinson and Company, Vygon and Poly Medicure Limited
Strategies Deployed in Intravenous Equipment Market
Sep-2022: Teleflex Incorporated took over Standard Bariatrics, Inc., a provider of superior Bariatric/Metabolic Surgery clinical and economic outcome solutions for Patients and Healthcare Providers. With this acquisition, Teleflex Incorporated would be able to provide innovative powered stapling technology to their customers, for bariatric surgery.
Sep-2022: B. Braun Melsungen AG completed the acquisition of the Catheter Securement Devices portfolio of Starboard Medical, a medical devices manufacturing company. Through this acquisition, B. Braun would be able to meet the needs and requirements of their customers, as an innovative Clik-FIX portfolio is added to the expertise and commercial capabilities of B. Braun.
Jan-2022: ICU Medical acquired Smiths Medical from Smiths Group PLC. Smith Medical business comprises vascular access, syringe and ambulatory infusion devices, and vital care products. The combined operations, when coupled with ICU Medical's current businesses, created a market-leading infusion therapy company with pro forma combined revenues of about $2.5 billion. The acquisition of Smiths Medical complemented ICU Medical's current operations effectively and provided a sizable US-based international rival that strengthened the medical supply chain's stability and expanded as clinical care models changed.
Dec-2021: Becton, Dickinson, and Company completed the acquisition of Venclose, Inc., a medical technology company that develops solutions for the treatment of chronic venous insufficiency. Through this acquisition, Becton, Dickinson, and Company would be able to deliver a strong portfolio of solutions to the physicians who are treating venous conditions.
Dec-2021: Baxter International, Inc. took over Hillrom, a medical technology company that offers patient support systems, surgical solutions, and front-line care products. Through this acquisition, both companies will be able to accelerate the development process of their products and offerings. Moreover, this acquisition would also help to expand the geographic footprint of Baxter and create new opportunities in the digital health market.
Nov-2019: Terumo Corporation signed an agreement to acquire Aortica Corporation, a U.S.-based company that provides personalized vascular therapy solutions. With this acquisition, Aortica's advanced products and software solutions would be added to Terumo's product portfolio. Moreover, this acquisition would be a great opportunity for both companies to accelerate the development of new and innovative products.
Market Segments covered in the Report:
By Product Type
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures